Members |
targetComponentId |
Diverticulosis of the large intestine NOS |
Diverticulosis of large intestine (finding) |
Diverticulosis of the small intestine NOS |
Diverticular disease of small intestine |
Diverticulum of duodenum with complication |
Diverticulum of duodenum |
Diverticulum of duodenum without complication |
Diverticulum of duodenum |
Division Tenericutes |
Phylum Mycoplasmatota (organism) |
Division of palmar aponeurosis for repair of Dupuytren contracture |
Division of palmar aponeurosis for correction of Dupuytren contracture (procedure) |
Do not turn patient |
Turning patient contraindicated |
Dobutamine 12.5mg/mL infusion concentrate 20mL vial |
Product containing precisely dobutamine (as dobutamine hydrochloride) 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Dobutamine 50mg/mL infusion concentrate 5mL ampule |
Dobutamine (as dobutamine hydrochloride) 50 mg/mL solution for injection |
Dobutamine hydrochloride 12.5mg/ml infusion concentrate 20ml vial |
Product containing precisely dobutamine (as dobutamine hydrochloride) 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Does not, dependent |
Does not |
Dog allergy vaccine |
Dog allergy vaccine (product) |
Doll's eye sign |
Doll's head reflex |
Dolphin distemper virus |
Cetacean morbillivirus (organism) |
Domain Archaea |
Domain Archaea |
Domestic animal species, non-primate |
Class Mammalia (organism) |
Domestic animals |
Class Mammalia (organism) |
Domestic helper/maid NOS |
Domestic helpers/maids |
Domestic helper/maid NOS |
Domestic helpers/maids |
Domestic partner of subject |
Domestic partner (person) |
Domiciliary service NOS |
Domiciliary services |
Domiciliary service NOS |
Provision of domiciliary services |
Domiciliary visit done NOS |
Domiciliary visit received |
Domiciliary visit done NOS |
Domiciliary visit received |
Domiciliary visit request NOS |
Domiciliary visit requested |
Domiciliary visit request NOS |
Domiciliary visit requested |
Donepezil 10mg orally disintegrating tablet |
Product containing precisely donepezil hydrochloride 10 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Donepezil 1mg/mL oral solution |
Donepezil hydrochloride 1 mg/mL oral solution |
Donepezil 5mg orally disintegrating tablet |
Donepezil hydrochloride 5 mg orodispersible tablet |
Dopamine hydrochloride 160mg/mL infusion concentrate 5mL ampule |
Product containing precisely dopamine hydrochloride 160 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Dopamine hydrochloride 40mg/mL infusion concentrate 5mL ampule |
Dopamine hydrochloride 40 mg/mL solution for injection |
Dopexamine hydrochloride 10mg/mL infusion concentrate 5mL ampule |
Product containing precisely dopexamine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Dornase alfa 2500units(2.5mg) nebulizer solution |
Dornase alfa 1 mg/mL solution for nebuliser |
Dorsal dermal sinus |
A rare closed dysraphism with stalk characterised by a dorsal midline dermal sinus tract lined by keratinising stratified squamous epithelium extending to the intrathecal space. Other components such as hair follicles and shafts, mesenchymal derivatives (blood vessels and fibrous tissue) and occasionally nerve fibres can be observed. Inflamed granulation tissue containing mixed neutrophils, plasma cells, lymphocytes, and histiocytes is consistently found in the tract. It can also be associated with an intradural dermoid cyst. This malformation is at risk to cause intrathecal infections (meningitis, empyema) that justify prophylactic surgery. |
Dorsal finger flap |
Flap (substance) |
Dorsal metatarsal fasciocutaneous flap |
Dorsal metatarsal artery fasciocutaneous flap |
Dorsal thumb flap |
Flap (substance) |
Dorsal tongue flap |
Flap (substance) |
Dorsalis pedis flap |
Dorsalis pedis artery flap |
Dorsolateral sulcus |
Medulla oblongata dorsal lateral sulcus |
Dose form by site prepared for |
Pharmaceutical dose form (dose form) |
Dothiepin hydrochloride 25mg/5mL conventional release oral elixir |
Dosulepin 5 mg/mL oral solution |
Dothiepin hydrochloride 25mg/5mL s/f elixir |
Dosulepin 5 mg/mL oral solution |
Dothiepin hydrochloride 75mg/5mL conventional release oral elixir |
Dosulepin 15 mg/mL oral solution |
Dothiepin hydrochloride 75mg/5mL s/f elixir |
Dosulepin 15 mg/mL oral solution |
Double - DT - vaccination (& [pre-school] ) |
Preschool administration of diphtheria and tetanus vaccine |
Double - DT - vaccination |
Preschool administration of diphtheria and tetanus vaccine |
Double pedicle flap graft |
Reconstruction using bipedicled flap |
Down's incontinence apparatus |
Incontinence appliance |
Down's screening blood test NOS |
Down's screening status |
Down's screening blood test NOS |
Down's screening - blood test |
Down's syndrome NOS |
Complete trisomy 21 syndrome |
Down's syndrome NOS |
Complete trisomy 21 syndrome |
Doxazosin mesylate 8mg tablet |
Doxazosin (as doxazosin mesilate) 8 mg oral tablet |
Doxepin hydrochloride 10mg/mL oral solution |
Product containing precisely doxepin (as doxepin hydrochloride) 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
Doxepin metabolite |
Product containing doxepin (medicinal product) |
Doxorubicin hydrochloride 10mg injection solution vial |
Doxorubicin hydrochloride 10 mg powder for solution for injection vial |
Doxorubicin hydrochloride 20mg injection solution vial |
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Doxorubicin liposomal 20mg/10ml injection |
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Doxycycline 100mg dispersible tablet |
Doxycycline 100 mg orodispersible tablet |
Doxycycline 40mg m/r capsule |
Product containing precisely doxycycline 40 milligram/1 each prolonged-release oral capsule (clinical drug) |
Doxycycline 75mg orally disintegrating tablet |
Doxycycline anhydrous (as doxycycline) 75 mg orodispersible tablet |
Doxycycline calcium 50mg/5mL syrup |
Product containing precisely doxycycline anhydrous (as doxycycline calcium) 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Doxycycline hyclate 10% subgingival delivery system |
Product containing only doxycycline in oromucosal dose form (medicinal product form) |
Doxycycline hyclate 200mg injection (pdr for recon) |
Product containing only doxycycline in parenteral dose form (medicinal product form) |
Doxycycline hyclate 200mg powder for injection solution vial |
Product containing only doxycycline in parenteral dose form (medicinal product form) |
Doxycycline monohydrate 25mg/5mL suspension |
Doxycycline anhydrous (as doxycycline) 5 mg/mL oral suspension |
Draftsman NOS |
Draughtsman |
Drain insertion - action |
To put in between or into a part(s) of the body. |
Drainage bleb, functional |
Functional filtering bleb (finding) |
Drainage of boil of skin NEC |
Drainage of boil of skin |
Drainage of cyst NEC |
Drainage procedure |
Drainage of cyst of pancreas into jejunum NEC |
Pancreaticocystojejunostomy (procedure) |
Drainage of female perineal abscess |
Drainage of perineal abscess (procedure) |
Drainage of male periurethral abscess |
Drainage of periurethral abscess (procedure) |
Drainage of organ NOC |
Drainage procedure |
Drainage of organ NOC NOS |
Drainage procedure |
Draughtsman NOS |
Draughtsman |
Drechslera longirostrata |
Exserohilum longirostratum |
Dressing - action |
Application - action |
Dried factor IX fraction heated 600iu powder and solvent for injection solution vial |
Product containing only coagulation factor IX in parenteral dose form (medicinal product form) |
Dried factor IX fraction heated 600iu powder for conventional release solution for injection solution vial |
Product containing only coagulation factor IX in parenteral dose form (medicinal product form) |
Drilling of organ NOC |
Drilling |
Drimaren brilliant yellow |
Textile colours and finishes patch test substance |
Driving examination NOS |
Driving-related medical examination |
Driving examination NOS |
Driving-related medical examination |
Drop attacks in middle-aged woman |
Drop attack |
Dropping sensation- pelvic floor |
Sensation of pelvic floor heaviness (finding) |
Dropping sensation- pelvic floor |
Sensation of pelvic floor heaviness (finding) |
Drostanolone propionate allergy |
Allergy to drostanolone (finding) |
Drotrecogin alfa (activated) 5mg powder for infusion solution vial |
Drotrecogin alfa 5 mg powder for solution for injection vial |
Drotrecogin alfa 20mg powder for infusion solution vial |
Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Drug |
Pharmaceutical / biologic product (product) |
Drug abuse in remission |
Harmful pattern of substance use in remission |
Drug addiction counseling |
Counseling for substance dependence (procedure) |
Drug addiction notif NOS |
Drug addiction notification status |
Drug addiction notif NOS |
Drug addiction notification |
Drug aerosol, 0,01% |
Drug aerosol |
Drug aerosol, 0,04% |
Drug aerosol |
Drug aerosol, 0,5% |
Drug aerosol |
Drug cream, 0,01% |
A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. |